UBS’s Nuveen Core Equity Alpha Fund JCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$2.22M Buy
129,336
+11,639
+10% +$209K ﹤0.01% 2811
2014
Q2
$2.14M Sell
117,697
-92,878
-44% -$1.64M ﹤0.01% 2803
2014
Q1
$3.69M Sell
210,575
-54,833
-21% -$941K ﹤0.01% 2160
2013
Q4
$4.51M Buy
265,408
+43,472
+20% +$709K ﹤0.01% 1968
2013
Q3
$3.44M Buy
221,936
+19,229
+9% +$302K ﹤0.01% 2051
2013
Q2
$3.04M Buy
+202,707
New +$3.12M ﹤0.01% 2085

Other funds holding JCE

UBS's JCE Position: Q3 2014 in Review

UBS increased its Nuveen Core Equity Alpha Fund (JCE) stake by 9.9% in Q3 2014, buying an estimated $209K and bringing the position to 129,336 shares worth $2.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2811.

UBS first reported a position in JCE in Q2 2013 and has held it in 6 quarters since. The position peaked at $4.51M in Q4 2013. 28 funds tracked by Wall St. Rank hold JCE as of Q3 2014.

  • UBS held 129,336 shares of Nuveen Core Equity Alpha Fund worth $2.22M as of Q3 2014.
  • UBS bought 11,639 Nuveen Core Equity Alpha Fund shares in Q3 2014, an estimated $209K.
  • Nuveen Core Equity Alpha Fund made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2811 holding.
  • UBS first reported a position in Nuveen Core Equity Alpha Fund in Q2 2013 and has held it in 6 quarters since.
  • UBS's Nuveen Core Equity Alpha Fund position peaked at $4.51M in Q4 2013.
  • 28 funds tracked by Wall St. Rank held Nuveen Core Equity Alpha Fund as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.